These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 26813954)
21. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma. Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905 [TBL] [Abstract][Full Text] [Related]
22. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma. Su H; Wang H; Shi G; Zhang H; Sun F; Ye D Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989 [TBL] [Abstract][Full Text] [Related]
24. Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications. Rydzanicz M; Wrzesiński T; Bluyssen HA; Wesoły J Cancer Lett; 2013 Dec; 341(2):111-26. PubMed ID: 23933176 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma. Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930 [TBL] [Abstract][Full Text] [Related]
26. Expression of parafibromin in clear cell papillary renal cell carcinoma. Cui C; Ziober A; Bing Z Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):322-5. PubMed ID: 23060304 [TBL] [Abstract][Full Text] [Related]
27. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC. Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222 [TBL] [Abstract][Full Text] [Related]
28. Identification of KIF20A as a tumor biomarker and forwarder of clear cell renal cell carcinoma. Xiao W; Chen K; Liang HG; Zhang XP Chin Med J (Engl); 2021 Jan; 134(17):2137-2139. PubMed ID: 33410636 [No Abstract] [Full Text] [Related]
29. The expression analysis of NGAL and NGALR in clear cell renal cell carcinoma. Liu F; Li N; Yang W; Wang R; Yu J; Wang X Gene; 2018 Nov; 676():269-278. PubMed ID: 30138675 [TBL] [Abstract][Full Text] [Related]
30. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208 [TBL] [Abstract][Full Text] [Related]
31. Personalized discovery of altered pathways in clear cell renal cell carcinoma using accumulated normal sample data. Wang X; Ding M; Yang Y; Feng Y; Shi Z; Qiu F; Zhu M J BUON; 2016; 21(2):390-8. PubMed ID: 27273949 [TBL] [Abstract][Full Text] [Related]
32. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Requena MJ; Carrasco JC; Alvarez-Kindelan J Anal Quant Cytol Histol; 2008 Dec; 30(6):336-7. PubMed ID: 19160698 [No Abstract] [Full Text] [Related]
33. [Possibilities of molecular diagnosis of renal cell carcinoma]. Junker K Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022 [TBL] [Abstract][Full Text] [Related]
34. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma. Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications. Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794 [TBL] [Abstract][Full Text] [Related]
36. Kidney cancer: not a single disease. Pospihalj B; Zamparese R; Mazzucchelli R; Morichetti D Anal Quant Cytol Histol; 2007 Dec; 29(6):377-9. PubMed ID: 18228653 [No Abstract] [Full Text] [Related]
37. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma. Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513 [TBL] [Abstract][Full Text] [Related]
38. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma. Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555 [TBL] [Abstract][Full Text] [Related]
39. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
40. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma. Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]